A new pattern of comprehensive treatment for hepatocellular carcinoma
10.3760/cma.j.cn115610-20231208-00243
- VernacularTitle:肝癌综合治疗新格局
- Author:
Jianqiang CAI
1
;
Hong ZHAO
;
Xiao CHEN
Author Information
1. 国家癌症中心国家肿瘤临床医学研究中心 中国医学科学院 北京协和医学院肿瘤医院肝胆外科,北京 100021
- Keywords:
Liver neoplasms;
Neoadjuvant therapy;
Conversion therapy;
Surgical pro-cedures, operative;
Multi‐disciplinary team;
Efficacy
- From:
Chinese Journal of Digestive Surgery
2024;23(2):204-208
- CountryChina
- Language:Chinese
-
Abstract:
Surgical treatment is the primary curative approach for hepatocellular carcinoma (HCC). In China, the proportion of advanced HCC is high, with a low rate of surgical removal at initial diagnosis and a high rate of postoperative recurrence, posing a serious threat to public health. With the advent of new therapeutic drugs and updated treatment concepts, the comprehensive treatment of HCC has entered a new era. Systemic treatments represented by targeted therapy and immuno-therapy, non-surgical local treatments such as interventional and radiotherapy, and the combination of systemic and local treatments, have significantly improved the treatment efficacy, bringing hope to patients. The authors review past studies, summarize diagnostic and treatment experience, and discuss the comprehensive treatment strategy for HCC in the era of targeted and immunotherapy, with surgery as the main approach.